Capesaris: Phase II started

In September, GTx said it began the open-label, U.S. Phase II G200712 trial to evaluate 125,

Read the full 169 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE